ClinicalTrials.Veeva
Menu

Find clinical trials for Diabetes in London, England

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Diabetes Mellitus
Type 2 Diabetes Mellitus
Type 1 Diabetes Mellitus
Diabetic Foot
Foot Ulcer
Obesity
Ulcer

Diabetes trials near London, England, GBR:

Anti-viral Action Against Type 1 Diabetes Autoimmunity

of type 1 diabetes.The primary objective is to determine whether vaccination of children with elevated genetic risk for type 1 diabetes...

Enrolling
Diabetes Mellitus, Type 1
Drug: Sodium Chloride 0.9% Inj
Drug: Comirnaty Injectable Product

Phase 4

Technical University of Munich

Cambridge, United Kingdom and 7 other locations

months (+ 14 days) to children with elevated genetic risk for type 1 diabetes reduces the cumulative incidence of beta-cell autoantibodies i...

Active, not recruiting
Diabetes Mellitus, Type 1
Dietary Supplement: Placebo
Dietary Supplement: B. infantis
Helmholtz Zentrum München

Cambridge, United Kingdom and 7 other locations

A trial of patients with type 2 diabetes mellitus to evaluate the comparative effectiveness between dapagliflozin and Standard of Care (SOC)...

Active, not recruiting
Type 2 Diabetes Mellitus
Drug: Standard of Care
Drug: Dapagliflozin

Phase 4

University of Liverpool

London, United Kingdom and 131 other locations

The purpose of this study is to assess the safety and efficacy (including durability) of up to 2 REACT injections given 3 months (+30 days) apart and...

Enrolling
Type 2 Diabetes Mellitus
Chronic Kidney Diseases
Biological: Renal Autologous Cell Therapy (REACT)
Procedure: Sham Comparator

Phase 3

Prokidney

London, United Kingdom and 55 other locations

To compare in diabetic patients eligible for percutaneous coronary intervention (PCI) with minimal exclusion criteria, the efficacy and safe...

Active, not recruiting
Diabetes
Coronary Artery Disease
Device: XIENCE Everolimus Eluting Coronary Stent System (XIENCE family)
Device: Abluminus DES+ Sirolimus Eluting Stent System (SES)
Concept Medical
Concept Medical

London, United Kingdom and 89 other locations

+ 12-week 800kcal/day low-energy diet, delivered remotely) is more likely to lead to weight loss and remission in adults with type 2 diabetes...

Invitation-only
Diabetes Mellitus, Type 2
Combination Product: Digital therapeutic and intensive lifestyle programme
Other: Standard of care
Habitual Health

London, United Kingdom

The purpose of this study is to investigate the efficacy and safety of retatrutide compared with placebo in participants with Type 2 Diabetes...

Enrolling
Type 2 Diabetes
Drug: Retatrutide
Drug: Placebo

Phase 3

Lilly
Lilly

Stevenage, Hertfordshire, United Kingdom and 79 other locations

Closed Loop system (HCL) in adult and pediatric patients with type 1 diabetes in the home setting. A diverse population of patients with typ...

Active, not recruiting
Type 1 Diabetes
Device: Subject's Current Diabetes Therapy
Device: 670G and 770G Insulin Pump
Medtronic
Medtronic

Cambridge, United Kingdom and 35 other locations

Locations recently updated

This study will look at the long-term effects of semaglutide (active medicine) on diabetic eye disease when compared to placebo (dummy medic...

Active, not recruiting
Diabetes Mellitus, Type 2
Drug: Semaglutide
Drug: Placebo (semaglutide)

Phase 3

Novo Nordisk
Novo Nordisk

London, United Kingdom and 177 other locations

This study will look at the effects of CagriSema in people with both type 2 diabetes and painful diabetic peripheral neuropathy, co...

Not yet enrolling
Diabetes Mellitus, Type 2
Diabetic Peripheral Neuropathy
Drug: CagriSema (Cagrilintide B and Semaglutide I)
Drug: Placebo matched to CagriSema (Cagrilintide B and Semaglutide I)

Phase 2

Novo Nordisk
Novo Nordisk

London, United Kingdom and 43 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems